Please use this identifier to cite or link to this item: https://doi.org/10.1186/1471-2334-14-289
Title: A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: The ASSURE study
Authors: Stryjewski M.E.
Lentnek A.
O'Riordan W.
Pullman J.
Tambyah P.A.
Miró J.M.
Fowler Jr. V.G.
Barriere S.L.
Kitt M.M.
Corey G.R.
Issue Date: 2014
Publisher: BioMed Central Ltd.
Citation: Stryjewski M.E., Lentnek A., O'Riordan W., Pullman J., Tambyah P.A., Miró J.M., Fowler Jr. V.G., Barriere S.L., Kitt M.M., Corey G.R. (2014). A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: The ASSURE study. BMC Infectious Diseases 14 (1) : 289. ScholarBank@NUS Repository. https://doi.org/10.1186/1471-2334-14-289
Source Title: BMC Infectious Diseases
URI: http://scholarbank.nus.edu.sg/handle/10635/143213
ISSN: 14712334
DOI: 10.1186/1471-2334-14-289
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
1471-2334-14-289.pdf584.97 kBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

38
checked on Dec 17, 2018

WEB OF SCIENCETM
Citations

33
checked on Dec 17, 2018

Page view(s)

3
checked on Jun 21, 2018

Download(s)

1
checked on Jun 21, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.